Credit: Daniel Shu, Mark Yarchoan
Blood from patients participating on the clinical trial shows that antitumor immune cells expanded with treatment, providing a possible mechanism for how a personalized vaccine can be used to improve immune responses against cancer.
close
-
News keyboard_arrow_right
Latest News Coronavirus News Currently Embargoed News Research News Releases Google Fact Check Research Alert Preprints Marketplace News with Video/Audio
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right